<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Skin surgery: Prevention and treatment of complications</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Skin surgery: Prevention and treatment of complications</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Skin surgery: Prevention and treatment of complications</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Simon A Ritchie, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stanley J Miller, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Rosamaria Corona, MD, DSc</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 06, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H3968536229"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Dermatologic surgical procedures performed in outpatient settings are generally low-risk procedures. Perioperative and postoperative complications in dermatologic surgery are infrequent, with an overall rate of 1 to 9 percent, and are minor in most cases [<a href="#rid1">1-5</a>].</p><p>The most common complications related to surgical excisions of skin lesions and their prevention and management will be reviewed in this topic. Complications related to injury of nerves or other relevant anatomic structures during cutaneous surgery of the head and neck are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/13706.html" rel="external">"Anatomic danger zones for nerve injury in cutaneous surgery of the head and neck"</a>.)</p><p class="headingAnchor" id="H482895538"><span class="h1">OBTAINING INFORMED CONSENT</span><span class="headingEndMark"> — </span>Clinicians must provide adequate information to the patient regarding the patient's diagnosis, proposed treatment, and risks and benefits of the treatment, and informed written consent should be obtained. Thoroughly discussing the risks of the procedure and alternative treatment options will set appropriate expectations regarding the outcome and will instill confidence in the patient that the clinician will be able to manage potential complications. Moreover, obtaining informed consent will help reduce discontent and litigation when complications occur. (See  <a class="medical medical_review" href="/z/d/html/15076.html" rel="external">"Informed procedural consent"</a>.)</p><p class="headingAnchor" id="H889695382"><span class="h1">PREVENTING WRONG SITE SURGERY</span><span class="headingEndMark"> — </span>Wrong site surgery is a rare but preventable complication in skin surgery. Steps to undertake before surgery to prevent wrong site surgery may include [<a href="#rid6">6-8</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Marking the surgical or biopsy site with surgical marker</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Taking a high-quality digital picture of the marked lesion that includes one or more visible anatomic landmarks</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Using an anatomical surgical diagram to record the lesion site</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Performing a final time-out where the patient or family/caregiver confirms the patient identification, procedure, and surgical site</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Reviewing clinical notes carefully</p><p></p><p class="headingAnchor" id="H517750354"><span class="h1">PERIOPERATIVE COMPLICATIONS</span><span class="headingEndMark"> — </span>Anxiety, pain, adverse effects of local anesthesia, and bleeding are the most common perioperative complications. Although they are mild and relatively easy to address in most cases, they can considerably impact the patient's perception of their overall experience in the office.</p><p class="headingAnchor" id="H790325704"><span class="h2">Procedural anxiety</span><span class="headingEndMark"> — </span>A patient's concern that they will experience untoward effects during or after the surgical procedure may lead to anxiety. Mild anxiety prior to a procedure is not uncommon. Often, a discussion with the patient and/or caregiver about <strong>why</strong> the patient is anxious, which can include fears of pain during or after the procedure, excessive bleeding, or scarring with cosmetic or functional consequences, can ameliorate the anxiety through a realistic description of the procedure and its aftercare.</p><p>Acute procedural anxiety is an excessive fear of surgical procedures that results in acute distress in anticipation of or during the procedure. The management of procedural anxiety with medications and/or psychologic interventions is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/16851.html" rel="external">"Acute procedural anxiety and specific phobia of clinical procedures in adults: Treatment overview"</a>.)</p><p class="headingAnchor" id="H1085887023"><span class="h2">Pain</span><span class="headingEndMark"> — </span>The two main sources of perioperative pain are the administration of the local anesthetic and the procedure itself if insufficient anesthetic is administered. The measures to decrease pain and discomfort associated with the administration of local anesthesia, including buffering the local anesthetic solution with <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">sodium bicarbonate</a> if it contains <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a>, using a small-gauge needle, and distraction, are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/6324.html" rel="external">"Subcutaneous infiltration of local anesthetics", section on 'Methods to decrease injection pain'</a>.)</p><p>Additional anesthesia may be needed if the patient experiences pain, even if minimal, during the procedure. It is thus advisable to have anesthetic on the procedure tray to avoid delays with the procedure.</p><p class="headingAnchor" id="H2303802928"><span class="h2">Adverse effects of local anesthetics</span><span class="headingEndMark"> — </span>Adverse effects of local anesthetics, including <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> toxicity, catecholamine sensitivity, vasovagal syncope, and allergic reactions, are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6324.html" rel="external">"Subcutaneous infiltration of local anesthetics", section on 'Complications'</a> and  <a class="medical medical_review" href="/z/d/html/1050.html" rel="external">"Reflex syncope in adults and adolescents: Clinical presentation and diagnostic evaluation"</a> and  <a class="medical medical_review" href="/z/d/html/14929.html" rel="external">"Clinical use of local anesthetics in anesthesia", section on 'Allergic reactions'</a>.)</p><p class="headingAnchor" id="H1926603240"><span class="h2">Intraoperative bleeding</span><span class="headingEndMark"> — </span>A small amount of bleeding and bruising is expected during a surgical procedure. Excessive bleeding may be due to a combination of patient-related factors, including use of anticoagulants and comorbidities, and procedure-related factors, such as laceration of small arterioles or wide undermining [<a href="#rid9">9,10</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Arterial bleeding</strong> – Arterial bleeding presents as a pulsatile, fast-rate flow of bright red blood coming from the wound. Although the prevention of arterial hemorrhage can be difficult, an understanding of the vascular anatomy of the procedure area, particularly in high-risk zones of the head and neck, will allow the surgeon to proceed with caution and avoid laceration of small arterioles. Areas such as the temple (where the temporal artery runs relatively superficial) or the scalp (where the blood vessels are attached to the superficial fascia, which prevents vasoconstriction) are common areas where difficult-to-control arteriolar hemorrhage can occur. (See  <a class="medical medical_review" href="/z/d/html/13706.html" rel="external">"Anatomic danger zones for nerve injury in cutaneous surgery of the head and neck"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Venous bleeding</strong> – Venous bleeding, or "oozing," occurs most frequently in patients taking anticoagulants and in those with underlying disorders of coagulation. In these patients, bleeding may be conspicuous and obscure the surgical field. This type of bleeding can be minimized by using anesthetics that contain <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a>. If oozing is anticipated in a patient on anticoagulants, the clinician should wait approximately 10 minutes after administering the anesthesia before beginning the procedure as the vasoconstrictive effect of epinephrine is maximal after 10 to 15 minutes.</p><p></p><p class="headingAnchor" id="H1003553639"><span class="h2">Patients on anticoagulants and antiplatelet agents</span><span class="headingEndMark"> — </span>Data from several randomized trials, observational studies, and meta-analyses indicate that the risk of severe bleeding in patients undergoing cutaneous surgery while taking direct oral anticoagulants or antiplatelet agents is generally low [<a href="#rid11">11,12</a>]. In a meta-analysis of randomized trials and cohort studies that compared the rates of bleeding and thromboembolic events during cutaneous surgery in patients receiving anticoagulation (n = 9214) versus patients not receiving it (n = 21,696), the rates of bleeding complications were 3.5 and 1.2 percent, respectively [<a href="#rid13">13</a>]. No difference was observed in hemorrhage rates among patients whose antithrombotic therapy was stopped versus continued (odds ratio 1.16, 95% CI 0.73-1.83; p = 0.54).</p><p>Therefore, there is general consensus that patients undergoing cutaneous surgery should continue their oral anticoagulant, antithrombotic, and antiplatelet medications, as the benefits of reducing the risk of thromboembolic events outweigh the lightly increased risk of intraoperative and postoperative bleeding [<a href="#rid14">14</a>]. (See  <a class="medical medical_review" href="/z/d/html/1312.html" rel="external">"Perioperative management of patients receiving anticoagulants", section on 'Settings in which continuing the anticoagulant may be preferable'</a>.)</p><p>In patients taking <a class="drug drug_general" data-topicid="10050" href="/z/d/drug information/10050.html" rel="external">warfarin</a>, it is important to confirm that the international normalized ratio is within the therapeutic range at the time of the procedure [<a href="#rid15">15,16</a>]. In select patients undergoing complex surgery and reconstruction, clinicians should coordinate with the physician managing the anticoagulation medication before modifying the medication [<a href="#rid14">14</a>].</p><p><a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">Aspirin</a> or nonsteroidal anti-inflammatory drugs (NSAIDs) taken for primary prevention or for the treatment of pain can be discontinued five to seven days before the procedure and then reinitiated within 24 hours after the procedure.</p><p class="headingAnchor" id="H1905710824"><span class="h2">Management of intraoperative hemorrhage</span><span class="headingEndMark"> — </span>Venous bleeding/oozing and small arteriolar hemorrhages during cutaneous procedures are, in most cases, easily controlled by applying direct pressure to the area and electrocautery:</p><p class="bulletIndent1"><span class="glyph">●</span>Have an assistant bring two hemostats (if not already on the tray) along with additional gauze, as needed. In areas such as the scalp, where there are several vascular anastomoses, the hemorrhage will often occur from both lacerated sides of the vessel, thereby requiring the two hemostats.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Slowly roll back the gauze to expose the lacerated vessel and immediately clamp it with the hemostat.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Apply cautery directly to the clamped vessel or to the hemostat. When employing the latter technique, the vessel is grasped with a pair of pickups or the hemostat and elevated away from the skin. Then, the metal tip of the cautery device is applied to the instrument, and the cautery device is activated until an audible popping sound comes from the vessel. (See  <a class="medical medical_review" href="/z/d/html/2890.html" rel="external">"Overview of electrosurgery", section on 'Cutting and coagulation currents'</a>.)</p><p></p><p>Larger arterial hemorrhages can be controlled by placing an absorbable figure-of-eight ligating suture around the vessel proximal to the site of laceration. The clamping instrument is then slowly released to ensure that the suture is correctly placed and bleeding is controlled.</p><p>Continued hemostasis can be promoted by postoperative use of appropriate pressure dressings for 24 to 48 hours [<a href="#rid17">17</a>].</p><p class="headingAnchor" id="H2597579491"><span class="h1">POSTOPERATIVE COMPLICATIONS</span></p><p class="headingAnchor" id="H3009624277"><span class="h2">Hematoma</span><span class="headingEndMark"> — </span>A hematoma is a collection of blood underneath a wound that has been sutured closed. It results from poor coagulation of vessels that were lacerated during the procedure and presents as a tense, sometimes painful expansion underneath the wound, sometimes with surrounding ecchymoses  (<a class="graphic graphic_picture graphicRef115041 graphicRef115042" href="/z/d/graphic/115041.html" rel="external">picture 1A-B</a>). There is usually scant, if any, blood visible on the skin overlying the sutured wound, which can sometimes make diagnosis more difficult. Occasionally, the overlying skin may become necrotic from the intense pressure of the blood collection underneath.</p><p>Postoperative hematomas occur infrequently in skin procedures. Predisposing factors include inadequate hemostasis during the procedure, cessation of the vasoconstrictor effect of the <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> injected with the local anesthetic, wide undermining of tissues adjacent to the wound, and postsurgery trauma (even minor). In a multicenter cohort study that included nearly 21,000 Mohs surgeries, the overall rate of adverse events was 0.72 percent, and the bleeding/hematoma rate was 0.1 percent [<a href="#rid4">4</a>].</p><p>Patients on anticoagulant therapy and those with congenital defects of coagulation have the highest risk of developing hematomas. In these patients, small vessels that appear to be no longer bleeding when closing the defect can bleed again after the wound is closed.</p><p class="headingAnchor" id="H3125404968"><span class="h3">Prevention</span><span class="headingEndMark"> — </span>Because hematomas, especially if large, can cause wound dehiscence and infection, meticulous hemostasis during surgery is essential to prevent this complication. The following measures can help reduce the likelihood of hematoma formation:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hemostasis</strong> – Electrocautery of the wound bed, especially the subcutaneous tissue, should be meticulously performed to ensure adequate hemostasis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Limiting undermining</strong> – In patients at risk for hematoma formation, undermining should be limited to the minimal amount necessary for proper wound healing and tissue mobility.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Drain placement</strong> – In patients at increased risk for hematoma (anticoagulant use, large surgical wounds, wide undermining), the placement of a drain can help to prevent hematoma formation. A small-diameter, sterile Penrose drain or the finger of a sterile surgical glove with the tip cut off (for smaller wounds) can be used. The drain should extend across the entire cavity of the wound and stick out of the lowermost side of the incision by approximately 1 cm, where it is sutured in place to prevent accidental removal. The patient should be seen in 24 hours, and if no further significant bleeding has occurred in the interim, the drain can be removed. If active bleeding is still occurring, the drain should be left in place for an additional 24 hours (or longer if necessary) until all bleeding has resolved. As an alternative to drain placement, the last 1 to 2 cm of the gravity-dependent end of the wound can be left open to allow drainage.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pressure dressings</strong> – Following all skin surgeries, a pressure dressing should be applied and left in place for 24 to 48 hours.</p><p></p><p class="headingAnchor" id="H1042489895"><span class="h3">Management</span><span class="headingEndMark"> — </span>Prompt management of hematomas is important to ensure proper wound healing and prevent infection. For small, stable hematomas (&lt;2 cm and not expanding), observation is a reasonable approach. Larger hematomas or hematomas causing significant symptoms should be drained.</p><p>Within 24 to 48 hours of development, hematomas can be drained either by aspiration using a syringe and a 14-gauge needle or by making a small opening into the gravity-dependent portion of the wound and applying a gentle pressure on the area. For hematomas older than 48 hours, the wound is partially opened and evacuated.</p><p>After hematoma evacuation, it is advisable to monitor the wound for 10 to 15 minutes to ensure that the bleeding has stopped. If significantly more blood accumulates in that time, the wound should be completely reopened under local anesthesia, and the responsible vessel should be identified and dealt with appropriately. If no bleeding is evident after an additional 10 to 15 minutes, the wound can be repaired.</p><p>Once a wound has been opened, regardless of the opening size, the risk of dehiscence and infection is high. Wounds that have been reopened or show evidence of infection should be allowed to heal by secondary intention with the application of petrolatum and a protective dressing. (See  <a class="medical medical_review" href="/z/d/html/15912.html" rel="external">"Basic principles of wound management"</a>.)</p><p>If clinical signs of wound infection develop, prompt antibiotic therapy should be initiated. (See <a class="local">'Surgical site infection'</a> below.)</p><p class="headingAnchor" id="H2246992188"><span class="h2">Dehiscence</span><span class="headingEndMark"> — </span>Surgical wounds occasionally dehisce despite a carefully performed layered closure. Wound dehiscence typically occurs within the first postoperative week but can occur later in patients with underlying conditions associated with poor wound healing. Reasons for dehiscence include:</p><p class="bulletIndent1"><span class="glyph">●</span>High-tension areas (superior trunk, proximal upper extremities)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Atrophic skin (advanced age, previously irradiated skin)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Poor patient compliance with postsurgical instructions</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Use of medications that inhibit wound healing, such as systemic corticosteroids, mechanistic target of rapamycin (mTOR) inhibitors (<a class="drug drug_general" data-topicid="10329" href="/z/d/drug information/10329.html" rel="external">sirolimus</a>, <a class="drug drug_general" data-topicid="9078" href="/z/d/drug information/9078.html" rel="external">everolimus</a>), or hedgehog pathway inhibitors (<a class="drug drug_general" data-topicid="17142" href="/z/d/drug information/17142.html" rel="external">vismodegib</a>, <a class="drug drug_general" data-topicid="103072" href="/z/d/drug information/103072.html" rel="external">sonidegib</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Poor circulation</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Underutilization of deep, absorbable sutures to close the wound</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Development of infection</p><p></p><p>In most cases, surgical wounds dehisce because of excessive mechanical stress placed on the wound too soon after surgery or inadequate reinforcement of the wound with sutures  (<a class="graphic graphic_picture graphicRef115045" href="/z/d/graphic/115045.html" rel="external">picture 2</a>).</p><p class="headingAnchor" id="H3626091833"><span class="h3">Prevention</span><span class="headingEndMark"> — </span>Surgical wounds that are sutured closed regain strength over weeks and reach a maximum of 80 percent of normal skin strength several months postoperatively [<a href="#rid18">18</a>]. Therefore, the wound must not experience significant stress in the first few weeks after surgery.</p><p>Patients should be warned that the strength of the wound sutures may be overpowered even by mild activity.</p><p class="bulletIndent1"><span class="glyph">●</span>For trunk and upper extremity wounds, it is reasonable to limit patients to lifting no more than 15 pounds for two weeks after surgery, gradually increasing activity as tolerated. Aerobic activity such as walking is usually not an issue for wound healing and can be continued within a day or two of surgery.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For lower extremity wounds, patients may need to elevate the extremity to decrease edema, which can also place significant stress on a healing wound.</p><p></p><p class="headingAnchor" id="H2034534276"><span class="h3">Management</span><span class="headingEndMark"> — </span>Wounds that have dehisced after cutaneous procedures are usually allowed to heal by secondary intention. Patients should apply a thin layer of petrolatum by using a cotton tip applicator and cover the wound with nonadherent gauze. The dressing is changed daily until complete re-epithelization has occurred. Topical or systemic antibiotics are not needed in these situations unless there is overt evidence of soft tissue infection.</p><p class="headingAnchor" id="H1218933626"><span class="h2">Surgical site infection</span><span class="headingEndMark"> — </span>Surgical site infection (SSI) is defined as an infection related to an operative procedure that occurs at or near the surgical incision within 30 days of the procedure [<a href="#rid19">19</a>].</p><p>In dermatologic surgery, SSIs are uncommon, with reported overall rates of approximately &lt;1 to 9 percent [<a href="#rid5">5,20-23</a>]. Higher rates are reported for specific sites (eg, groin, lower extremities) or surgical technique (eg, flaps, grafts) and in patients with predisposing underlying conditions (eg, immunosuppression, corticosteroid use, diabetes, obesity) [<a href="#rid24">24,25</a>]. However, in a single-institution review of 1864 skin grafts (92 percent full thickness), the SSI rate among the 1754 patients who had not received preoperative antibiotic was 1.1 percent [<a href="#rid26">26</a>].</p><p>SSIs usually manifest within three to five days of the procedure. Pain is the most sensitive indicator of infection. Other clinical findings, such as erythema, induration, and fluctuance, help distinguish an SSI from the expected inflammation that characterizes the early phase of wound healing; in severe infections, a purulent discharge from the wound may be present [<a href="#rid27">27</a>].</p><p>Although rarely associated with significant morbidity, postoperative infections can cause discomfort and interfere with normal wound healing. In high-risk patients (eg, immunosuppressed patients, patients at risk for infective endocarditis or prosthetic joint infection), SSI can be associated with significant morbidity and, rarely, mortality.</p><p class="headingAnchor" id="H2005318678"><span class="h3">Prevention</span><span class="headingEndMark"> — </span>Prevention of SSI involves preoperative, intraoperative, and postoperative infection-control interventions, including skin antisepsis, use of mask and gloves, and use of perioperative antibiotics. (See  <a class="medical medical_review" href="/z/d/html/4044.html" rel="external">"Overview of control measures for prevention of surgical site infection in adults"</a>.)</p><p class="headingAnchor" id="H3030671008"><span class="h4">Skin antisepsis</span><span class="headingEndMark"> — </span>Common antiseptics include povidone-based preparations, chlorhexidine-based preparations, and ethyl alcohol. Among them, chlorhexidine-based preparations appear to be more effective than povidone-based preparations in preventing SSI [<a href="#rid28">28,29</a>]. (See  <a class="medical medical_review" href="/z/d/html/4044.html" rel="external">"Overview of control measures for prevention of surgical site infection in adults", section on 'Skin antisepsis'</a>.)</p><p class="headingAnchor" id="H1981803512"><span class="h4">Sterile versus nonsterile gloves</span><span class="headingEndMark"> — </span>Sterile glove use, which for many years was thought to decrease the risk of SSI in outpatient dermatologic procedures, has been shown to have no effect on the incidence of these infections. For this reason, we use nonsterile gloves when performing simple dermatologic procedures in the clinic.</p><p class="bulletIndent1"><span class="glyph">●</span>In a 2016 systematic review and meta-analysis of eight randomized trials and five observational studies including over 11,000 patients undergoing minor surgery in outpatient settings, the SSI rates in the nonsterile and sterile glove groups were similar (2.1 and 2 percent, respectively; pooled relative risk [RR] 1.06, 95% CI 0.81-1.39) [<a href="#rid30">30</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>These findings were confirmed in a subsequent small, subject-blinded randomized trial that included 93 patients who underwent routine skin cancer excision with sterile or nonsterile gloves [<a href="#rid31">31</a>]. No wound infections occurred at 48 to 72 hours postoperatively in either group.</p><p></p><p>However, sterile gloves are appropriate for more complex cutaneous surgeries requiring reconstruction.</p><p class="headingAnchor" id="H4952364"><span class="h4">Antibiotic prophylaxis</span><span class="headingEndMark"> — </span>Despite the low incidence of SSI following skin surgery, most skin surgeons prescribe systemic antibiotic prophylaxis preoperatively. In a survey of 177 surgeons from the American College of Mohs Surgery and the American Society for Mohs Surgery, systemic antibiotics were prescribed preoperatively and postoperatively by 96 and 91 percent of the surgeons, respectively [<a href="#rid32">32</a>].</p><p class="headingAnchor" id="H462781017"><span class="h5">Systemic</span><span class="headingEndMark"> — </span>Systemic antibiotic prophylaxis for the prevention of SSI is indicated in the following circumstances  (<a class="graphic graphic_algorithm graphicRef79756" href="/z/d/graphic/79756.html" rel="external">algorithm 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>If the wound is contaminated or infected. The degree of contamination of a surgical wound at the time of the operation is an important risk factor for infection [<a href="#rid33">33</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients who are at high risk for SSI based on the site (lips, oral mucosa, ears, nose, groin, or lower extremities), technique used (skin flaps or grafts), underlying conditions (eg, immunosuppression, diabetes, obesity, malnutrition), or lifestyle habits (eg, tobacco smoking).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients at high risk for infective endocarditis [<a href="#rid34">34-36</a>]. (See  <a class="medical medical_review" href="/z/d/html/2147.html" rel="external">"Prevention of endocarditis: Antibiotic prophylaxis and other measures"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients at high risk of hematogenous joint infection. (See  <a class="medical medical_review" href="/z/d/html/7667.html" rel="external">"Prevention of prosthetic joint and other types of orthopedic hardware infection", section on 'Following hardware placement'</a>.)</p><p></p><p>The antibiotic selection and regimens based upon the surgical site and potential pathogens present at specific sites are illustrated in the table  (<a class="graphic graphic_table graphicRef69096" href="/z/d/graphic/69096.html" rel="external">table 1</a>) [<a href="#rid37">37</a>].</p><p>The efficacy of antibiotic prophylaxis has been evaluated in a few randomized trials with conflicting results:</p><p class="bulletIndent1"><span class="glyph">●</span>A meta-analysis of three randomized trials (n = 839) assessing the efficacy of preoperative antibiotic prophylaxis in the prevention of SSI in patients undergoing Mohs surgery for ear and nose tumors found that antibiotics were no more effective than placebo in reducing the risk of SSI (pooled risk ratio 0.81, 95% CI 0.31-2.11) [<a href="#rid38">38</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A randomized trial evaluated the efficacy of a single dose of 2 g oral <a class="drug drug_general" data-topicid="9231" href="/z/d/drug information/9231.html" rel="external">cephalexin</a> in preventing SSI in 154 patients undergoing complex skin closure on the nose and ear [<a href="#rid39">39</a>]. SSI occurred in 1.4 percent of patients in the active intervention group compared with 12 percent in the placebo group.</p><p></p><p class="headingAnchor" id="H3083483044"><span class="h5">Intraincisional</span><span class="headingEndMark"> — </span>Intraincisional antibiotic prophylaxis with an extremely small dose of antibiotics achieves high local tissue concentration with negligible amounts entering the circulation, thus reducing the risk of systemic adverse effects and development of antibiotic resistance. Its efficacy in reducing the risk of SSI in patients undergoing skin surgery has been evaluated in a few observational studies and randomized trials:</p><p class="bulletIndent1"><span class="glyph">●</span>In a 2023 randomized trial, 735 patients presenting for standard surgical excision of skin cancer received incision site injection of buffered local anesthetic alone (<a class="drug drug_general" data-topicid="9559" href="/z/d/drug information/9559.html" rel="external">lidocaine-epinephrine</a> 1%/1:100,000 buffered 1:10 with <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">sodium bicarbonate</a> 8.4%), local anesthetic with 500 mcg flucloxacillin, or buffered local anesthetic with 500 mcg <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">clindamycin</a> [<a href="#rid40">40</a>]. The rate of SSI was 5.7 percent in the local anesthetic alone group, 5.3 percent in the flucloxacillin group, and 2.1 percent in the clindamycin group. No adverse events were reported.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a retrospective series of 11,412 patients undergoing Mohs surgery who received a dose of 408 mcg of <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">clindamycin</a> mixed with buffered <a class="drug drug_general" data-topicid="9559" href="/z/d/drug information/9559.html" rel="external">lidocaine-epinephrine</a>, SSI occurred in 0.3 percent of patients [<a href="#rid41">41</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a meta-analysis of two randomized trials (n = 2080), intraincisional antibiotic prophylaxis reduced the incidence of SSI compared with no antibiotic (pooled risk ratio 0.18, 95% CI 0.05-0.71) [<a href="#rid38">38</a>].</p><p></p><p class="headingAnchor" id="H2819599528"><span class="h4">Postoperative topical antibiotics</span><span class="headingEndMark"> — </span>The potential of topical antibiotics to induce allergic contact dermatitis (ACD) and antibiotic resistance have lead most dermatologists to recommend using only white petrolatum for the management of surgical wounds healing either by primary or secondary intention [<a href="#rid42">42,43</a>]. However, the use of topical antibiotics in the postoperative period may have a small benefit in the prevention of SSI compared with no antibiotic. A 2016 meta-analysis of eight moderate-quality trials (5427 participants) found that topical antibiotics are associated with a modest reduction of SSI risk in people with surgical wounds healing by primary intention compared with no topical antibiotic (RR 0.61, 95% CI 0.42-0.87) [<a href="#rid44">44</a>].</p><p class="headingAnchor" id="H3929128127"><span class="h3">Management</span><span class="headingEndMark"> — </span>In the absence of systemic symptoms (eg, fever, chills), SSIs can be treated on an outpatient basis. Patients with SSI and systemic symptoms should be transported to the emergency department for treatment. SSIs with evidence of fluctuance are treated with incision and drainage and a course of systemic antibiotics. Infections associated with cellulitis alone are treated with systemic antibiotics alone. (See  <a class="medical medical_review" href="/z/d/html/138447.html" rel="external">"Skin abscesses in adults: Treatment"</a> and  <a class="medical medical_review" href="/z/d/html/110530.html" rel="external">"Acute cellulitis and erysipelas in adults: Treatment"</a>.)</p><p>Before initiating antibiotic treatment, a culture from the wound should be obtained to identify the responsible organism. Empiric antibiotic treatment against methicillin-susceptible <em>Staphylococcus aureus</em> and beta-hemolytic streptococci (<em>Streptococcus pyogenes</em>), which are the most common causes of SSI, should be initiated immediately, pending culture and susceptibility results. Oral <a class="drug drug_general" data-topicid="9231" href="/z/d/drug information/9231.html" rel="external">cephalexin</a> is a common choice as first-line therapy  (<a class="graphic graphic_table graphicRef69096" href="/z/d/graphic/69096.html" rel="external">table 1</a>).</p><p>In patients at high risk for methicillin-resistant <em>Staphylococcus aureus</em> (MRSA) colonization  (<a class="graphic graphic_table graphicRef53504" href="/z/d/graphic/53504.html" rel="external">table 2</a>), empiric antibiotic treatment providing coverage against MRSA should be used as first-line therapy. <a class="drug drug_general" data-topicid="9785" href="/z/d/drug information/9785.html" rel="external">Trimethoprim-sulfamethoxazole</a>, <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">clindamycin</a>, and <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> or <a class="drug drug_general" data-topicid="9653" href="/z/d/drug information/9653.html" rel="external">minocycline</a> have good activity against MRSA  (<a class="graphic graphic_table graphicRef69096" href="/z/d/graphic/69096.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/z/d/html/3176.html" rel="external">"Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Treatment of skin and soft tissue infections"</a>.)</p><p>SSIs that are treated promptly and appropriately usually have an excellent prognosis. Patients with SSI should be seen in clinic approximately one week after the initiation of antibiotics to ensure resolution.</p><p class="headingAnchor" id="H1872959341"><span class="h2">Contact dermatitis</span><span class="headingEndMark"> — </span>Cutaneous inflammatory reactions to medical tapes, adhesives, topical anesthetics, and topical antibiotics are relatively common complications of cutaneous surgery.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Allergic contact dermatitis</strong> – Certain topical antibiotics (eg, <a class="drug drug_general" data-topicid="9686" href="/z/d/drug information/9686.html" rel="external">neomycin</a>, <a class="drug drug_general" data-topicid="9052" href="/z/d/drug information/9052.html" rel="external">bacitracin</a>), topical anesthetics (eg, <a class="drug drug_general" data-topicid="9092" href="/z/d/drug information/9092.html" rel="external">benzocaine</a>), and surgical tapes and adhesives (colophonium) are common topical sensitizers that can elicit a delayed allergic response [<a href="#rid45">45</a>]. Depending on whether the patient has been previously exposed to the offending substance, the reaction can take hours to several days to become apparent.</p><p></p><p class="bulletIndent1">ACD from surgical tapes and adhesives typically has a sharply demarcated, geometric appearance matching that of the tape  (<a class="graphic graphic_picture graphicRef131589" href="/z/d/graphic/131589.html" rel="external">picture 3</a>). (See  <a class="medical medical_review" href="/z/d/html/13655.html" rel="external">"Clinical features and diagnosis of allergic contact dermatitis"</a> and  <a class="medical medical_review" href="/z/d/html/13665.html" rel="external">"Management of allergic contact dermatitis in adults"</a>.)</p><p></p><p class="bulletIndent1">ACD is often misdiagnosed as an infection as the cutaneous manifestations, including erythema, scaling, and crusting, resemble those of a superficial infection. An important distinguishing feature, however, is the primary symptom. While pain in the wound area is the predominant complaint of patients with SSI, pruritus is the cardinal symptom of ACD and is often intense and unrelenting.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nonallergic reactions</strong> – Nonallergic reactions to tapes and adhesives are common [<a href="#rid46">46</a>]. These include superficial skin injury, tension injury, and irritant contact dermatitis.</p><p></p><p class="headingAnchor" id="H778141043"><span class="h3">Prevention</span><span class="headingEndMark"> — </span>ACD can be prevented by counseling patients about avoidance of known sensitizers (eg, topical antibiotics, topical analgesics) for the care of their surgical wounds. Although topical antibiotics may slightly reduce the risk of SSI compared with petrolatum [<a href="#rid44">44</a>], we prefer petrolatum for the care of surgical wounds because of its wound healing and nonsensitizing properties. Systemic nonopioid analgesics (eg, <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">acetaminophen</a>) rather than topical anesthetics should be used for pain control.</p><p class="headingAnchor" id="H30698876"><span class="h3">Management</span><span class="headingEndMark"> — </span>The most important step in treating ACD is to remove the offending agent (see  <a class="medical medical_review" href="/z/d/html/13665.html" rel="external">"Management of allergic contact dermatitis in adults"</a>). If a topical antibiotic is suspected, the patient should be instructed to apply only white petrolatum to the wound. If tape is suspected, alternative options include using paper tape (which is less adherent but generally less sensitizing) to keep the dressing in place or using a rolled gauze to wrap the wound if the wound is on an extremity. Small wounds can be left open after the second postoperative day, covered only with a thin layer of petrolatum.</p><p>Simply removing the offending agent may not provide symptomatic relief to a patient with severe ACD. For localized reactions (1 to 2 percent of the total body surface area), a high-potency topical corticosteroid ointment (eg, <a class="drug drug_general" data-topicid="9276" href="/z/d/drug information/9276.html" rel="external">clobetasol</a> propionate 0.05% ointment) applied once or twice daily as needed until resolution of the pruritus will provide symptomatic relief without adversely affecting wound healing. Once the pruritus has subsided, the patient may discontinue the use of the topical corticosteroid and apply white petrolatum only to the wound.</p><p>Oral H1 antihistamines can be used as an adjunctive therapy to control pruritus if not contraindicated. Typically, sedating antihistamines, such as <a class="drug drug_general" data-topicid="9369" href="/z/d/drug information/9369.html" rel="external">diphenhydramine</a> or <a class="drug drug_general" data-topicid="8544" href="/z/d/drug information/8544.html" rel="external">hydroxyzine</a> (both given orally at doses of 25 to 50 mg every six hours), are the most effective at providing relief. (See  <a class="medical medical_review" href="/z/d/html/5576.html" rel="external">"Pruritus: Therapies for localized pruritus"</a>.)</p><p class="headingAnchor" id="H1728494269"><span class="h2">Suture reactions</span><span class="headingEndMark"> — </span>A suture reaction is an inflammatory, foreign body reaction against the absorbable suture material left in place. It typically presents with erythema around the wound, often with a linear arrangement of small, erythematous papules or pustules. Suture reactions are commonly misdiagnosed by patients as SSIs because they often have a purulent discharge. Two important features differentiating a suture reaction from an SSI are the appearance of discrete, erythematous papules, pustules, or erosions in a linear fashion (corresponding to the location of the deep, absorbable sutures that were placed) and the timeframe of occurrence. Suture reactions most commonly manifest one to three months after the procedure, whereas infections occur mostly within the first postoperative week.</p><p>Most suture reactions are mildly symptomatic and do not require treatment. However, if sutures are visible, they should be removed. Occasionally, the knots tied in the absorbable subcutaneous sutures may perforate through the wound, preventing full wound healing. The knots can usually be gently grasped with pickups and removed painlessly. Patients can be reassured that the final appearance of the wound will not be affected by this temporary setback.</p><p class="headingAnchor" id="H1188337512"><span class="h2">Hypergranulation</span><span class="headingEndMark"> — </span>Granulation tissue is the result of the combined production of collagen and growth of capillaries that occurs in secondary intention healing. (See  <a class="medical medical_review" href="/z/d/html/15080.html" rel="external">"Basic principles of wound healing", section on 'Phases of wound healing'</a>.)</p><p>On occasion, this physiologic process can become excessive, leading to the formation of an exuberant, exophytic mass of granulation tissue that rises above the level of the wound and prevents re-epithelialization, a phenomenon called hypergranulation or overgranulation. Excessive granulation tissue can form focally or involve the entire wound base. It is most commonly seen in large defects allowed to heal by secondary intention, in particular when excessive moisture builds up underneath an occlusive dressing.</p><p>Excess granulation tissue can be treated with various techniques:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Silver nitrate</strong> – <a class="drug drug_general" data-topicid="9888" href="/z/d/drug information/9888.html" rel="external">Silver nitrate</a> is a cauterizing chemical available in liquid or solid form (stick) commonly used for removal of granulation tissue [<a href="#rid47">47</a>]. It is applied to the involved area by the surgeon in the office for a few consecutive days until the granulation tissue has receded.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intralesional or topical corticosteroids</strong> – Intralesional or topical high-potency corticosteroids have been reported as effective in reducing exuberant granulation tissue and promoting healing in surgical and burn wounds [<a href="#rid48">48-51</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Electrocautery</strong> – After infiltration of local anesthetic, the wound base is cauterized to reduce the vascular supply to the granulation tissue and induce regression.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Laser therapy</strong> – Laser therapy using the 595 nm pulsed dye laser followed by hydrocolloid dressing has been successfully used in a few series of patients with nonhealing surgical wounds due to hypergranulation [<a href="#rid52">52,53</a>]. Other types of lasers, including the ablative fractional carbon dioxide (CO<sub>2</sub>) laser and the potassium titanyl phosphate laser, have been successfully used in a few patients [<a href="#rid54">54,55</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Curettage</strong> – Curettage can be done with or without local anesthesia, depending upon the area's sensitivity. Using a 3 to 5 mm curette, the granulation tissue can be gently debrided away. Hemostasis is achieved with <a class="drug drug_general" data-topicid="9888" href="/z/d/drug information/9888.html" rel="external">silver nitrate</a> or electrocautery.</p><p></p><p>Limiting excessive moisture in the wound area is important to prevent recurrence. This can be accomplished in several ways, including:</p><p class="bulletIndent1"><span class="glyph">●</span>Applying dressings that contain <a class="drug drug_general" data-topicid="95641" href="/z/d/drug information/95641.html" rel="external">aluminum acetate</a> solution to the wound or a 1:4 dilution of table vinegar to water</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Using less occlusive dressings that maintain the slightly moist wound environment</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Applying a thin film of petrolatum, rather than a thick glob, to the wound </p><p></p><p>Patients with excess granulation tissue should be seen on a regular basis until the wound has healed to assess for any recurrence and to treat as needed.</p><p class="headingAnchor" id="H3404702907"><span class="h2">Scarring</span><span class="headingEndMark"> — </span>Scarring is an unavoidable consequence of cutaneous surgery. Although the resulting scar is cosmetically and functionally acceptable in many cases, at times, scarring can be extensive and even cause functional limitations. </p><p>The main two types of abnormal scarring are keloids and hypertrophic scars [<a href="#rid56">56</a>]. The risk of abnormal scarring should be discussed with all patients prior to surgery. Patients with a history of keloids should be counseled that they have a high risk of developing one following surgery.</p><p>A keloid typically extends beyond the original defect  (<a class="graphic graphic_picture graphicRef97009" href="/z/d/graphic/97009.html" rel="external">picture 4</a>), whereas a hypertrophic scar presents as a raised, firm scar along the surgical wound that does not extend beyond the original defect  (<a class="graphic graphic_picture graphicRef97014" href="/z/d/graphic/97014.html" rel="external">picture 5</a>). Both keloids and hypertrophic scars may be pruritic and painful.</p><p>The pathogenesis, clinical manifestations, and management of keloids and hypertrophic scars are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5569.html" rel="external">"Keloids and hypertrophic scars"</a> and  <a class="medical medical_review" href="/z/d/html/99106.html" rel="external">"Laser therapy for hypertrophic scars and keloids"</a>.)</p><p class="headingAnchor" id="H2576849709"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Overview</strong> – Perioperative and postoperative complications in dermatologic surgery, including hemorrhage, hematoma, surgical site infection (SSI), dehiscence, and allergic contact dermatitis (ACD), are uncommon and minor in most cases. Clinicians must provide adequate information to the patient regarding the risks and benefits of treatment, and informed written consent should be obtained. Clinicians should follow appropriate steps to prevent wrong site surgery. (See <a class="local">'Obtaining informed consent'</a> above and <a class="local">'Preventing wrong site surgery'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Perioperative complications</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Adverse effects of local anesthetics</strong> – Adverse effects of local anesthetics, including <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> toxicity, catecholamine sensitivity, vasovagal syncope, and allergic reactions, are discussed separately. (See <a class="local">'Adverse effects of local anesthetics'</a> above and  <a class="medical medical_review" href="/z/d/html/6324.html" rel="external">"Subcutaneous infiltration of local anesthetics", section on 'Complications'</a> and  <a class="medical medical_review" href="/z/d/html/1050.html" rel="external">"Reflex syncope in adults and adolescents: Clinical presentation and diagnostic evaluation"</a> and  <a class="medical medical_review" href="/z/d/html/14929.html" rel="external">"Clinical use of local anesthetics in anesthesia", section on 'Allergic reactions'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Intraoperative bleeding</strong> – Excessive bleeding may be due to a combination of patient-related factors, including use of anticoagulants (see <a class="local">'Patients on anticoagulants and antiplatelet agents'</a> above) and comorbidities, and procedure-related factors, such as laceration of small arterioles or wide undermining.</p><p></p><p class="bulletIndent2">The available evidence indicates that the risk of severe bleeding in patients undergoing cutaneous surgery while taking direct oral anticoagulants or antiplatelet agents is generally low. For patients undergoing cutaneous surgery on anticoagulants or antiplatelet agents, we suggest continuation of these agents (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Patients on anticoagulants and antiplatelet agents'</a> above.)</p><p></p><p class="bulletIndent2">Venous bleeding/oozing and small arteriolar hemorrhages during cutaneous procedures are, in most cases, easily controlled by applying direct pressure to the area and electrocautery. Larger arterial hemorrhages can be controlled by placing an absorbable figure-of-eight ligating suture around the vessel proximal to the site of laceration. (See <a class="local">'Intraoperative bleeding'</a> above and <a class="local">'Management of intraoperative hemorrhage'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postoperative complications</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Hematoma </strong>– A hematoma is a collection of blood underneath a wound that has been sutured closed and presents as a tense expansion underneath the wound  (<a class="graphic graphic_picture graphicRef115041 graphicRef115042" href="/z/d/graphic/115041.html" rel="external">picture 1A-B</a>). Meticulous hemostasis during surgery and application of a pressure dressing after surgery are essential to prevent this complication. For hematomas that are &gt;2 cm, expanding, or causing significant symptoms, we suggest evacuation rather than observation (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). Others can be observed. (See <a class="local">'Hematoma'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Surgical site infection</strong> – SSI is defined as an infection related to an operative procedure that occurs at or near the surgical incision within 30 days of the procedure. (See <a class="local">'Surgical site infection'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Prevention</strong> – Prevention of SSI involves preoperative, intraoperative, and postoperative infection-control interventions, including skin antisepsis, use of mask and gloves, and perioperative administration of antibiotics in select circumstances.</p><p></p><p class="bulletIndent3">For patients at high risk for SSI (based on the site, technique used, or underlying conditions) and patients at high risk for infective endocarditis or hematogenous joint infection, we suggest perioperative systemic antibiotics  (<a class="graphic graphic_algorithm graphicRef79756" href="/z/d/graphic/79756.html" rel="external">algorithm 1</a> and <a class="graphic graphic_table graphicRef69096" href="/z/d/graphic/69096.html" rel="external">table 1</a>) (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). The choice of antibiotic is discussed elsewhere. (See <a class="local">'Prevention'</a> above and  <a class="medical medical_review" href="/z/d/html/4043.html" rel="external">"Antimicrobial prophylaxis for prevention of surgical site infection in adults"</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Management</strong> – SSIs with evidence of fluctuance are treated with incision and drainage and a course of systemic antibiotics. Infections associated with cellulitis alone are treated with systemic antibiotics alone. (See <a class="local">'Management'</a> above and  <a class="medical medical_review" href="/z/d/html/138447.html" rel="external">"Skin abscesses in adults: Treatment"</a> and  <a class="medical medical_review" href="/z/d/html/110530.html" rel="external">"Acute cellulitis and erysipelas in adults: Treatment"</a>.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Amici JM, Rogues AM, Lasheras A, et al. A prospective study of the incidence of complications associated with dermatological surgery. Br J Dermatol 2005; 153:967.</a></li><li><a class="nounderline abstract_t">Cook JL, Perone JB. A prospective evaluation of the incidence of complications associated with Mohs micrographic surgery. Arch Dermatol 2003; 139:143.</a></li><li><a class="nounderline abstract_t">Merritt BG, Lee NY, Brodland DG, et al. The safety of Mohs surgery: a prospective multicenter cohort study. J Am Acad Dermatol 2012; 67:1302.</a></li><li><a class="nounderline abstract_t">Alam M, Ibrahim O, Nodzenski M, et al. Adverse events associated with mohs micrographic surgery: multicenter prospective cohort study of 20,821 cases at 23 centers. JAMA Dermatol 2013; 149:1378.</a></li><li><a class="nounderline abstract_t">Schlager JG, Hartmann D, Wallmichrath J, et al. Patient-dependent risk factors for wound infection after skin surgery: A systematic review and meta-analysis. Int Wound J 2022; 19:1748.</a></li><li><a class="nounderline abstract_t">Mopuri N, Frew Q, Loh CYY, Dziewulski P. A multistep approach to preventing wrong site surgery in skin lesion excision. Arch Plast Surg 2021; 48:570.</a></li><li><a class="nounderline abstract_t">Starling J 3rd, Coldiron BM. Outcome of 6 years of protocol use for preventing wrong site office surgery. J Am Acad Dermatol 2011; 65:807.</a></li><li><a class="nounderline abstract_t">Alam M, Lee A, Ibrahimi OA, et al. A multistep approach to improving biopsy site identification in dermatology: physician, staff, and patient roles based on a Delphi consensus. JAMA Dermatol 2014; 150:550.</a></li><li><a class="nounderline abstract_t">Bunick CG, Aasi SZ. Hemorrhagic complications in dermatologic surgery. Dermatol Ther 2011; 24:537.</a></li><li><a class="nounderline abstract_t">Nast A, Ernst H, Rosumeck S, et al. Risk of complications due to anticoagulation during dermatosurgical procedures: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2014; 28:1603.</a></li><li><a class="nounderline abstract_t">Isted A, Cooper L, Colville RJ. Bleeding on the cutting edge: A systematic review of anticoagulant and antiplatelet continuation in minor cutaneous surgery. J Plast Reconstr Aesthet Surg 2018; 71:455.</a></li><li><a class="nounderline abstract_t">Eilers RE Jr, Goldenberg A, Cowan NL, et al. A Retrospective Assessment of Postoperative Bleeding Complications in Anticoagulated Patients Following Mohs Micrographic Surgery. Dermatol Surg 2018; 44:504.</a></li><li><a class="nounderline abstract_t">Bonadurer GF 3rd, Langeveld AP, Lalla SC, et al. Hemorrhagic complications of cutaneous surgery for patients taking antithrombotic therapy: a systematic review and meta-analysis. Arch Dermatol Res 2022; 314:533.</a></li><li><a class="nounderline abstract_t">Chen A, Albertini JG, Bordeaux JS, et al. Evidence-Based Clinical Practice Guideline: Reconstruction after Skin Cancer Resection. Dermatol Surg 2021; 47:891.</a></li><li><a class="nounderline abstract_t">Callahan S, Goldsberry A, Kim G, Yoo S. The management of antithrombotic medication in skin surgery. Dermatol Surg 2012; 38:1417.</a></li><li><a class="nounderline abstract_t">Palamaras I, Semkova K. Perioperative management of and recommendations for antithrombotic medications in dermatological surgery. Br J Dermatol 2015; 172:597.</a></li><li><a class="nounderline abstract_t">Brown DG, Wilkerson EC, Love WE. A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons. J Am Acad Dermatol 2015; 72:524.</a></li><li class="breakAll">Stasko T. Complications of cutaneous procedures. In: Dermatologic Surgery: Principles and Practice, 2nd ed, Roenigk HH, Roenigk HH Jr (Eds), Marcel Dekker, 1996. p.149.</li><li><a class="nounderline abstract_t">Horan TC, Gaynes RP, Martone WJ, et al. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992; 13:606.</a></li><li><a class="nounderline abstract_t">Dixon AJ, Dixon MP, Askew DA, Wilkinson D. Prospective study of wound infections in dermatologic surgery in the absence of prophylactic antibiotics. Dermatol Surg 2006; 32:819.</a></li><li><a class="nounderline abstract_t">Maragh SL, Brown MD. Prospective evaluation of surgical site infection rate among patients with Mohs micrographic surgery without the use of prophylactic antibiotics. J Am Acad Dermatol 2008; 59:275.</a></li><li><a class="nounderline abstract_t">Rogers HD, Desciak EB, Marcus RP, et al. Prospective study of wound infections in Mohs micrographic surgery using clean surgical technique in the absence of prophylactic antibiotics. J Am Acad Dermatol 2010; 63:842.</a></li><li><a class="nounderline abstract_t">Schlager JG, Patzer K, Wallmichrath J, et al. Surgical site infection in skin surgery-An observational study. Int Wound J 2023; 20:3514.</a></li><li><a class="nounderline abstract_t">Schlager JG, Hartmann D, Ruiz San Jose V, et al. Procedure-Related Risk Factors for Surgical Site Infection in Dermatologic Surgery. Dermatol Surg 2022; 48:1046.</a></li><li><a class="nounderline abstract_t">Delpachitra MR, Heal C, Banks J, et al. Risk Factors for Surgical Site Infection in Minor Dermatological Surgery: A Systematic Review. Adv Skin Wound Care 2019; 32:217.</a></li><li><a class="nounderline abstract_t">Marous M, Bax M, Smith FL, Brown M. Antibiotic prophylaxis for full thickness and split thickness skin grafts in Mohs micrographic surgery: A retrospective case series and review of the literature. J Am Acad Dermatol 2022; 87:1117.</a></li><li><a class="nounderline abstract_t">Hicks A, Mazumder A, Moody R, et al. Clinical Characteristics of Gram-Negative Surgical Site Infections in Patients Treated With Mohs Micrographic Surgery: A Retrospective Analysis. Dermatol Surg 2023; 49:981.</a></li><li><a class="nounderline abstract_t">Wade RG, Burr NE, McCauley G, et al. The Comparative Efficacy of Chlorhexidine Gluconate and Povidone-iodine Antiseptics for the Prevention of Infection in Clean Surgery: A Systematic Review and Network Meta-analysis. Ann Surg 2021; 274:e481.</a></li><li><a class="nounderline abstract_t">Ruffolo AM, Sampath AJ, Colbert S, Golda N. Preoperative Considerations for the Prevention of Surgical Site Infection in Superficial Cutaneous Surgeries: A Systematic Review. Facial Plast Surg Aesthet Med 2021; 23:205.</a></li><li><a class="nounderline abstract_t">Brewer JD, Gonzalez AB, Baum CL, et al. Comparison of Sterile vs Nonsterile Gloves in Cutaneous Surgery and Common Outpatient Dental Procedures: A Systematic Review and Meta-analysis. JAMA Dermatol 2016; 152:1008.</a></li><li><a class="nounderline abstract_t">Michener M, Xia Y, Larrymore D, et al. A comparison of infection rates during skin cancer excisions using nonsterile vs sterile gloves: A prospective randomized pilot study. J Cosmet Dermatol 2019; 18:1475.</a></li><li><a class="nounderline abstract_t">Erickson SP, Schneider SL, Cohen JL, et al. Perioperative Practices in Dermatologic Surgery. Dermatol Surg 2022; 48:924.</a></li><li class="breakAll">United States Centers for Disease Control and Prevention. National Healthcare Safety Network: Surgical Site Infection Event (SSI). www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf (Accessed on September 29, 2017).</li><li><a class="nounderline abstract_t">Wright TI, Baddour LM, Berbari EF, et al. Antibiotic prophylaxis in dermatologic surgery: advisory statement 2008. J Am Acad Dermatol 2008; 59:464.</a></li><li><a class="nounderline abstract_t">Cahill TJ, Harrison JL, Jewell P, et al. Antibiotic prophylaxis for infective endocarditis: a systematic review and meta-analysis. Heart 2017; 103:937.</a></li><li><a class="nounderline abstract_t">Thornhill MH, Dayer M, Lockhart PB, Prendergast B. Antibiotic Prophylaxis of Infective Endocarditis. Curr Infect Dis Rep 2017; 19:9.</a></li><li><a class="nounderline abstract_t">Rossi AM, Mariwalla K. Prophylactic and empiric use of antibiotics in dermatologic surgery: a review of the literature and practical considerations. Dermatol Surg 2012; 38:1898.</a></li><li><a class="nounderline abstract_t">Mourad A, Gniadecki R, Taher M. Oral and Intraincisional Antibiotic Prophylaxis in Mohs Surgery: A Systematic Review and Meta-analysis. Dermatol Surg 2020; 46:558.</a></li><li><a class="nounderline abstract_t">Rosengren H, Heal CF, Buttner PG. Effect of a single prophylactic preoperative oral antibiotic dose on surgical site infection following complex dermatological procedures on the nose and ear: a prospective, randomised, controlled, double-blinded trial. BMJ Open 2018; 8:e020213.</a></li><li><a class="nounderline abstract_t">Goh M, Hollewand C, McBride S, et al. Effect of Microdoses of Incisional Antibiotics on the Rate of Surgical Site Infections in Skin Cancer Surgery: A Randomized Clinical Trial. JAMA Surg 2023; 158:718.</a></li><li><a class="nounderline abstract_t">Soleymani T, Brodland DG, Zitelli JA. A retrospective case series evaluating the efficacy of preoperative, intra-incisional antibiotic prophylaxis in Mohs micrographic surgery: An effective method to reduce surgical-site infections and minimize systemic antibiotic use. J Am Acad Dermatol 2020; 83:1501.</a></li><li><a class="nounderline abstract_t">Nijhawan RI, Smith LA, Mariwalla K. Mohs surgeons' use of topical emollients in postoperative wound care. Dermatol Surg 2013; 39:1260.</a></li><li><a class="nounderline abstract_t">Saco M, Howe N, Nathoo R, Cherpelis B. Topical antibiotic prophylaxis for prevention of surgical wound infections from dermatologic procedures: a systematic review and meta-analysis. J Dermatolog Treat 2015; 26:151.</a></li><li><a class="nounderline abstract_t">Heal CF, Banks JL, Lepper PD, et al. Topical antibiotics for preventing surgical site infection in wounds healing by primary intention. Cochrane Database Syst Rev 2016; 11:CD011426.</a></li><li><a class="nounderline abstract_t">Atwater AR, Bembry R, Liu B, et al. Medical adhesive allergens: Retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 2001-2018. J Am Acad Dermatol 2022; 87:1024.</a></li><li><a class="nounderline abstract_t">Smith SM, Zirwas MJ. Nonallergic reactions to medical tapes. Dermatitis 2015; 26:38.</a></li><li><a class="nounderline abstract_t">McGrath J, Schofield O. Treatment of excessive granulation tissue with EMLA cream and 95% silver-nitrate pencils. Clin Exp Dermatol 1990; 15:468.</a></li><li><a class="nounderline abstract_t">Moio M, Mataro I, Accardo G, et al. Treatment of hypergranulation tissue with intralesional injection of corticosteroids: preliminary results. J Plast Reconstr Aesthet Surg 2014; 67:e167.</a></li><li><a class="nounderline abstract_t">McShane DB, Bellet JS. Treatment of hypergranulation tissue with high potency topical corticosteroids in children. Pediatr Dermatol 2012; 29:675.</a></li><li><a class="nounderline abstract_t">Jaeger M, Harats M, Kornhaber R, et al. Treatment of hypergranulation tissue in burn wounds with topical steroid dressings: a case series. Int Med Case Rep J 2016; 9:241.</a></li><li><a class="nounderline abstract_t">Margulies S, Marion T, Saikaly SK. Use of Potent Topical Corticosteroids (TCS) for Hypergranulation Tissue (HGT) in Pediatric Patients. Cureus 2022; 14:e28304.</a></li><li><a class="nounderline abstract_t">Wang SQ, Goldberg LH. Pulsed dye laser for the treatment of hypergranulation tissue with chronic ulcer in postsurgical defects. J Drugs Dermatol 2007; 6:1191.</a></li><li><a class="nounderline abstract_t">Moody MN, Landau JM, Goldberg LH, et al. 595 nm long pulsed dye laser with a hydrocolloid dressing for the treatment of hypergranulation tissue on the scalp in postsurgical defects. Dermatol Online J 2011; 17:2.</a></li><li><a class="nounderline abstract_t">Spring LK, Rohrer TE, Dover JS. Ablative Fractional Laser Resurfacing: A Novel Treatment for Hypergranulation Tissue. Dermatol Surg 2021; 47:301.</a></li><li><a class="nounderline abstract_t">Madden K, Paghdal KV, Cohen G. Potassium titanyl phosphate 532-nm laser for treatment of a chronic nonhealing exophytic wound with hypergranulation tissue. Dermatol Surg 2011; 37:716.</a></li><li><a class="nounderline abstract_t">Ogawa R. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis. Int J Mol Sci 2017; 18.</a></li></ol></div><div id="topicVersionRevision">Topic 17042 Version 9.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16225607" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : A prospective study of the incidence of complications associated with dermatological surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12588220" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : A prospective evaluation of the incidence of complications associated with Mohs micrographic surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22892283" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The safety of Mohs surgery: a prospective multicenter cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24080866" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Adverse events associated with mohs micrographic surgery: multicenter prospective cohort study of 20,821 cases at 23 centers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35229471" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Patient-dependent risk factors for wound infection after skin surgery: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34583449" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : A multistep approach to preventing wrong site surgery in skin lesion excision.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21764169" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Outcome of 6 years of protocol use for preventing wrong site office surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24599088" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : A multistep approach to improving biopsy site identification in dermatology: physician, staff, and patient roles based on a Delphi consensus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22515669" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Hemorrhagic complications in dermatologic surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25132203" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Risk of complications due to anticoagulation during dermatosurgical procedures: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29233507" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Bleeding on the cutting edge: A systematic review of anticoagulant and antiplatelet continuation in minor cutaneous surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29140870" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : A Retrospective Assessment of Postoperative Bleeding Complications in Anticoagulated Patients Following Mohs Micrographic Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34132885" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Hemorrhagic complications of cutaneous surgery for patients taking antithrombotic therapy: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34228675" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Evidence-Based Clinical Practice Guideline: Reconstruction after Skin Cancer Resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22734794" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The management of antithrombotic medication in skin surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25142961" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Perioperative management of and recommendations for antithrombotic medications in dermatological surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25486915" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25486915" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1334988" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16792648" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Prospective study of wound infections in dermatologic surgery in the absence of prophylactic antibiotics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18638628" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Prospective evaluation of surgical site infection rate among patients with Mohs micrographic surgery without the use of prophylactic antibiotics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20800320" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Prospective study of wound infections in Mohs micrographic surgery using clean surgical technique in the absence of prophylactic antibiotics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37156639" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Surgical site infection in skin surgery-An observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35862641" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Procedure-Related Risk Factors for Surgical Site Infection in Dermatologic Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30376456" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Risk Factors for Surgical Site Infection in Minor Dermatological Surgery: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35101529" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Antibiotic prophylaxis for full thickness and split thickness skin grafts in Mohs micrographic surgery: A retrospective case series and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37738243" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Clinical Characteristics of Gram-Negative Surgical Site Infections in Patients Treated With Mohs Micrographic Surgery: A Retrospective Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32773627" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : The Comparative Efficacy of Chlorhexidine Gluconate and Povidone-iodine Antiseptics for the Prevention of Infection in Clean Surgery: A Systematic Review and Network Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32721241" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Preoperative Considerations for the Prevention of Surgical Site Infection in Superficial Cutaneous Surgeries: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27487033" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Comparison of Sterile vs Nonsterile Gloves in Cutaneous Surgery and Common Outpatient Dental Procedures: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30661299" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : A comparison of infection rates during skin cancer excisions using nonsterile vs sterile gloves: A prospective randomized pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35862644" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Perioperative Practices in Dermatologic Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35862644" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Perioperative Practices in Dermatologic Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18694679" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Antibiotic prophylaxis in dermatologic surgery: advisory statement 2008.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28213367" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Antibiotic prophylaxis for infective endocarditis: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28233191" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Antibiotic Prophylaxis of Infective Endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22805432" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Prophylactic and empiric use of antibiotics in dermatologic surgery: a review of the literature and practical considerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30883482" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Oral and Intraincisional Antibiotic Prophylaxis in Mohs Surgery: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29674370" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Effect of a single prophylactic preoperative oral antibiotic dose on surgical site infection following complex dermatological procedures on the nose and ear: a prospective, randomised, controlled, double-blinded trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37223929" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Effect of Microdoses of Incisional Antibiotics on the Rate of Surgical Site Infections in Skin Cancer Surgery: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32502584" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : A retrospective case series evaluating the efficacy of preoperative, intra-incisional antibiotic prophylaxis in Mohs micrographic surgery: An effective method to reduce surgical-site infections and minimize systemic antibiotic use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23777421" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Mohs surgeons' use of topical emollients in postoperative wound care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24646178" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Topical antibiotic prophylaxis for prevention of surgical wound infections from dermatologic procedures: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27819748" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Topical antibiotics for preventing surgical site infection in wounds healing by primary intention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34875303" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Medical adhesive allergens: Retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 2001-2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25581669" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Nonallergic reactions to medical tapes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2279350" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Treatment of excessive granulation tissue with EMLA cream and 95% silver-nitrate pencils.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24725728" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Treatment of hypergranulation tissue with intralesional injection of corticosteroids: preliminary results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22612258" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Treatment of hypergranulation tissue with high potency topical corticosteroids in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27570466" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Treatment of hypergranulation tissue in burn wounds with topical steroid dressings: a case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36158443" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Use of Potent Topical Corticosteroids (TCS) for Hypergranulation Tissue (HGT) in Pediatric Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18189058" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Pulsed dye laser for the treatment of hypergranulation tissue with chronic ulcer in postsurgical defects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21810387" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : 595 nm long pulsed dye laser with a hydrocolloid dressing for the treatment of hypergranulation tissue on the scalp in postsurgical defects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31634256" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Ablative Fractional Laser Resurfacing: A Novel Treatment for Hypergranulation Tissue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21457396" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Potassium titanyl phosphate 532-nm laser for treatment of a chronic nonhealing exophytic wound with hypergranulation tissue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28287424" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
